TRUSTED FOR OUR EXPERIENCE

PROFESSIONAL PATENTS

Schlich offer our clients a combination of technical knowledge and legal experience, and a practical approach that reflects your commercial needs and resources. We can assist with drafting new patent applications, prosecuting applications to grant, advising on freedom-to-operate or infringement matters, or contentious proceedings (e.g. EPO oppositions and appeals).

Schlich Biotech Attorneys

PATENT SPECIALITIES

LIFE SCIENCES & BIOTECH

Our team of life scientists have a deep understanding of the emerging technologies in this rapidly developing area.

This is allied with their knowledge of the commercial importance of these technologies and how to use them to protect your position in the marketplace.

PATENT SPECIALITIES

CHEMICAL & PHARMACEUTICAL

Schlich specialises in life sciences, with all attorneys having a first degree in a life science, with many also having a doctorate, before obtaining patent attorney qualifications.

Our team of chemists and biochemists offer a combination of strong, technical knowledge with an experienced in the drafting and prosecution of patents in the UK, Europe and internationally.

Schlich Pharma
schlich-david-eyre

PATENT SPECIALITIES

MECHANICAL & OTHER TECHNOLOGIES

There is nothing like getting your hands on the inner workings of a lock or bike light or car part. We understand it’s vital to get to grips with what makes these devices work, so we can capture the best protection for our clients.

Latest Firm News

Update: Schlich Walks to the EPO!

Update: Schlich Walks to the EPO!

Working in kilometres (we are, after all, European Patent Attorneys), we have managed to walk approximately 530km and are officially more than halfway to Munich!  If we were to physically walk to...

read more
Schlich walks to the EPO!

Schlich walks to the EPO!

After the New Year’s confetti has been swept away, the biscuit selection boxes are demolished and everyone has settled back into the nine to five, it’s likely that some of our New Years resolutions may have already taken a backseat.

read more